NASDAQ:NBIX is not too expensive for the growth it is showing.

Our stock screening tool has pinpointed NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) as a growth stock that isn't overvalued. NASDAQ:NBIX is excelling in various growth indicators while maintaining a solid financial footing. Furthermore, it remains attractively priced. Let's delve into the specifics below.

Growth Insights: NASDAQ:NBIX

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:NBIX boasts a 9 out of 10:

• NBIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.17%, which is quite impressive.
• Measured over the past years, NBIX shows a very strong growth in Earnings Per Share. The EPS has been growing by 70.09% on average per year.
• Looking at the last year, NBIX shows a very strong growth in Revenue. The Revenue has grown by 26.76%.
• NBIX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.13% yearly.
• The Earnings Per Share is expected to grow by 42.64% on average over the next years. This is a very strong growth
• NBIX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.87% yearly.

Evaluating Valuation: NASDAQ:NBIX

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:NBIX has earned a 7 for valuation:

• NBIX's Price/Earnings ratio is rather cheap when compared to the industry. NBIX is cheaper than 94.92% of the companies in the same industry.
• Compared to the rest of the industry, the Price/Forward Earnings ratio of NBIX indicates a rather cheap valuation: NBIX is cheaper than 95.42% of the companies listed in the same industry.
• Based on the Enterprise Value to EBITDA ratio, NBIX is valued cheaper than 94.92% of the companies in the same industry.
• Compared to the rest of the industry, the Price/Free Cash Flow ratio of NBIX indicates a rather cheap valuation: NBIX is cheaper than 95.25% of the companies listed in the same industry.
• The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• The excellent profitability rating of NBIX may justify a higher PE ratio.
• NBIX's earnings are expected to grow with 53.13% in the coming years. This may justify a more expensive valuation.

Analyzing Health Metrics

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:NBIX, the assigned 7 for health provides valuable insights:

• NBIX has an Altman-Z score of 9.52. This indicates that NBIX is financially healthy and has little risk of bankruptcy at the moment.
• NBIX's Altman-Z score of 9.52 is amongst the best of the industry. NBIX outperforms 84.75% of its industry peers.
• NBIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
• NBIX has a Current Ratio of 2.45. This indicates that NBIX is financially healthy and has no problem in meeting its short term obligations.
• NBIX has a Quick Ratio of 2.40. This indicates that NBIX is financially healthy and has no problem in meeting its short term obligations.

Assessing Profitability for NASDAQ:NBIX

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:NBIX scores a 9 out of 10:

• With an excellent Return On Assets value of 7.68%, NBIX belongs to the best of the industry, outperforming 96.61% of the companies in the same industry.
• NBIX's Return On Equity of 11.19% is amongst the best of the industry. NBIX outperforms 96.27% of its industry peers.
• NBIX has a Return On Invested Capital of 11.21%. This is amongst the best in the industry. NBIX outperforms 96.61% of its industry peers.
• The last Return On Invested Capital (11.21%) for NBIX is above the 3 year average (9.89%), which is a sign of increasing profitability.
• NBIX's Profit Margin of 13.23% is amongst the best of the industry. NBIX outperforms 96.44% of its industry peers.
• NBIX's Profit Margin has improved in the last couple of years.
• NBIX has a Operating Margin of 20.92%. This is amongst the best in the industry. NBIX outperforms 96.95% of its industry peers.
• In the last couple of years the Operating Margin of NBIX has grown nicely.
• Looking at the Gross Margin, with a value of 97.90%, NBIX belongs to the top of the industry, outperforming 97.46% of the companies in the same industry.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of NBIX contains the most current fundamental analsysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.